Bruce Cohen

Featured in: Favicon

nature.com Favicon

harvard.edu Favicon

medscape.com Favicon

thelancet.com Favicon

psychiatryonline.org Favicon

mdedge.com Favicon

brainandlife.org Favicon

health.harvard.edu Favicon

ajp.psychiatryonline.org

Articles

Genotype-Specific Effects of Elamipretide in Patients With Primary Mitochondrial Myopathy: A Post Hoc Analysis of the MMPOWER-3 Trial

Jan 29, 2025 | digitalcommons.library.tmc.edu | Amel Karaa |Enrico Bertini |Valerio Carelli |Bruce Cohen

BACKGROUND: As previously published, the MMPOWER-3 clinical trial did not demonstrate a significant benefit of elamipretide treatment in a genotypically diverse population of adults with primary mitochondrial myopathy (PMM).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →